(Q40175508)

18 September 2017

1 reference

title

Better prognosis of many cancers in female: a phenomenon not explained by study of steroid receptors (English)

1 reference

18 September 2017

Better prognosis of many cancers in female: A phenomenon not explained by study of steroid receptors (English)

1 reference

https://api.crossref.org/works/10.1002/JSO.2930250408

10 October 2023

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6371384

10 October 2023

1 reference

https://api.crossref.org/works/10.1002/JSO.2930250408

10 October 2023

1 reference

https://api.crossref.org/works/10.1002/JSO.2930250408

10 October 2023

author name string

Y. T. Lee

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6371384

10 October 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6371384

10 October 2023

publication date

1 April 1984

1 reference

full work available at URL

18 September 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fjso.2930250408

1 reference

https://api.crossref.org/works/10.1002/JSO.2930250408

https://onlinelibrary.wiley.com/doi/full/10.1002/jso.2930250408

10 October 2023

1 reference

https://api.crossref.org/works/10.1002/JSO.2930250408

Journal of Surgical Oncology

10 October 2023

published in

1 reference

18 September 2017

volume

25

1 reference

18 September 2017

issue

4

1 reference

18 September 2017

page(s)

255-262

1 reference

Central Lymphatic Irradiation to Low Dose for Advanced Nodular Lymphoreticular Tumors (Non-Hodgkin's Lymphoma)

18 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FJSO.2930250408

Colonic neoplasms: tissue estrogen receptor and carcinoembryonic antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJSO.2930250408

Malignant melanoma: sex differences in survival after evidence of distant metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJSO.2930250408

Progesterone Receptor in Cystosarcoma Phyllodes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJSO.2930250408

Steroid hormone receptors in human colon cancers

21 January 2018

1

1 reference

https://api.crossref.org/works/10.1002/JSO.2930250408

Estrogen receptor values in patients with benign breast disease

10 October 2023

2

1 reference

https://api.crossref.org/works/10.1002/JSO.2930250408

Efficacy of Oophorectomy in Lymphangioleiomyomatosis and Benign Metastasizing Leiomyoma

10 October 2023

3

1 reference

https://api.crossref.org/works/10.1002/JSO.2930250408

Proceedings: Hormone-induced and spontaneous regression of metastatic renal cancer.

10 October 2023

4

1 reference

https://api.crossref.org/works/10.1002/JSO.2930250408

Glucocorticoid-induced exacerbation of metastatic human melanoma.

10 October 2023

7

1 reference

https://api.crossref.org/works/10.1002/JSO.2930250408

Extra-abdominal Desmoid Tumors

10 October 2023

10

1 reference

https://api.crossref.org/works/10.1002/JSO.2930250408

Metastasizing leiomyoma of the uterus. S-phase fraction, estrogen receptor, and ultrastructure

10 October 2023

13

1 reference

https://api.crossref.org/works/10.1002/JSO.2930250408

Phase II study of high-dose tamoxifen (NSC-180973) in patients with disseminated malignant melanoma

10 October 2023

14

1 reference

https://api.crossref.org/works/10.1002/JSO.2930250408

The Diagnosis and Treatment of Renal Cell Carcinoma

10 October 2023

15

1 reference

https://api.crossref.org/works/10.1002/JSO.2930250408

Absence of melanoma specificity in the reactivity of melanoma patients' sera with cultured allogeneic melanoma cell lines

10 October 2023

16

1 reference

https://api.crossref.org/works/10.1002/JSO.2930250408

Estrogen-receptor protein in intracranial meningiomas

10 October 2023

17

1 reference

https://api.crossref.org/works/10.1002/JSO.2930250408

Intra-arterial infusion therapy with 5-(3,3-dimeth yl-1-triazeno) imidazole-4-carboxamide (NSC 45388) for malignant melanoma

10 October 2023

20

1 reference

https://api.crossref.org/works/10.1002/JSO.2930250408

Chemotherapy studies in primary liver cancer. A prospective randomized clinical trial

10 October 2023

23

1 reference

https://api.crossref.org/works/10.1002/JSO.2930250408

Oestrogen receptors in human malignant melanoma

10 October 2023

24

1 reference

https://api.crossref.org/works/10.1002/JSO.2930250408

Estrogen receptors in male breast cancer: Clinical and pathologic correlations

10 October 2023

26

1 reference

https://api.crossref.org/works/10.1002/JSO.2930250408

A Reappraisal of the Results of Stopping Therapy in Childhood Leukemia

10 October 2023

27

1 reference

https://api.crossref.org/works/10.1002/JSO.2930250408

Estrogen receptors in male breast cancer

10 October 2023

28

1 reference

https://api.crossref.org/works/10.1002/JSO.2930250408

High risk acute lymphocytic leukemia: a study of 141 cases with initial white blood cell counts over 100,000/cu mm.

10 October 2023

29

1 reference

https://api.crossref.org/works/10.1002/JSO.2930250408

Previous pregnancy as a protective factor against death from melanoma

10 October 2023

30

1 reference

https://api.crossref.org/works/10.1002/JSO.2930250408

High rate of long-term survivals in AML treated by chemotherapy and androgenotherapy: a pilot study

10 October 2023

31

1 reference

https://api.crossref.org/works/10.1002/JSO.2930250408

Malignant melanoma of the skin occurring during pregnancy

10 October 2023

32

1 reference

https://api.crossref.org/works/10.1002/JSO.2930250408

Relationships between steroid receptor and epithelial cell proliferation in benign fibrocystic disease of the breast

10 October 2023

33

1 reference

https://api.crossref.org/works/10.1002/JSO.2930250408

10 October 2023

Cancer Treatment Reports

34

60

183

Johnson

1976

1 reference

https://api.crossref.org/works/10.1002/JSO.2930250408

Carcinoid and other tumors metastatic to the breast

10 October 2023

35

1 reference

https://api.crossref.org/works/10.1002/JSO.2930250408

Estrogen receptor protein in malignant carcinoid tumor: a report of 2 cases

10 October 2023

36

1 reference

https://api.crossref.org/works/10.1002/JSO.2930250408

Estrogen Receptor Assay in the Differential Diagnosis of Adenocarcinomas

10 October 2023

37

1 reference

https://api.crossref.org/works/10.1002/JSO.2930250408

Long-term survival in childhood acute leukemia: “Late” relapses

10 October 2023

38

1 reference

https://api.crossref.org/works/10.1002/JSO.2930250408

Estrogen receptors in the spectrum of breast cancer

10 October 2023

39

1 reference

https://api.crossref.org/works/10.1002/JSO.2930250408

An analysis of skin tests and their relationship to recurrence and survival in stage III and stage IV melanoma patients

10 October 2023

40

1 reference

https://api.crossref.org/works/10.1002/JSO.2930250408

Steroid receptors study in breast carcinoma

10 October 2023

41

1 reference

https://api.crossref.org/works/10.1002/JSO.2930250408

Steroid receptors in sarcomatous lesions

10 October 2023

42

1 reference

https://api.crossref.org/works/10.1002/JSO.2930250408

The New England Journal of Medicine

10 October 2023

43

301

47

Lerner

1979

1 reference

https://api.crossref.org/works/10.1002/JSO.2930250408

Predictability of response to endocrine ablation in advanced breast carcinoma. A correlation to estrogen receptor and steroid sulfurylation

10 October 2023

44

1 reference

https://api.crossref.org/works/10.1002/JSO.2930250408

The New England Journal of Medicine

10 October 2023

46

306

993

Mahoney

1982

1 reference

https://api.crossref.org/works/10.1002/JSO.2930250408

10 October 2023

Cancer Treatment Reports

47

65

531

Masiel

1981

1 reference

https://api.crossref.org/works/10.1002/JSO.2930250408

Biological aspects of human malignant melanoma

10 October 2023

50

1 reference

https://api.crossref.org/works/10.1002/JSO.2930250408

The New England Journal of Medicine

10 October 2023

53

301

1241

Nesbit

1979

1 reference

https://api.crossref.org/works/10.1002/JSO.2930250408

Subungual malignant melanoma: a clinical-pathologic study

10 October 2023

56

1 reference

https://api.crossref.org/works/10.1002/JSO.2930250408

10 October 2023

Estrogen Receptors

57

1 reference

https://api.crossref.org/works/10.1002/JSO.2930250408

Metastasis of maternal cancer to the placenta and fetus

10 October 2023

58

1 reference

https://api.crossref.org/works/10.1002/JSO.2930250408

Prognostic factors in metastatic malignant melanoma. The southeastern cancer study group experience

10 October 2023

59

1 reference

https://api.crossref.org/works/10.1002/JSO.2930250408

Most cystosarcoma phyllodes and fibroadenomas have progesterone receptor but lack estrogen receptor: Stromal localization of progesterone receptor

10 October 2023

62

1 reference

https://api.crossref.org/works/10.1002/JSO.2930250408

Disappearance of the predictive value of prognostic variables in childhood acute lymphoblastic leukemia: a report from Childrens Cancer Study Group

10 October 2023

65

1 reference

https://api.crossref.org/works/10.1002/JSO.2930250408

Differences in prognosis for boys and girls with acute lymphoblastic leukaemia

10 October 2023

66

1 reference

https://api.crossref.org/works/10.1002/JSO.2930250408

Further studies of biochemical predictive tests in breast cancer

10 October 2023

67

1 reference

https://api.crossref.org/works/10.1002/JSO.2930250408

Histologic features of tumors and the female superiority in survival from malignant melanoma

10 October 2023

68

1 reference

https://api.crossref.org/works/10.1002/JSO.2930250408

Malignant melanoma: influence of site of lesion and age of patient in the female superiority in survival

10 October 2023

69

1 reference

https://api.crossref.org/works/10.1002/JSO.2930250408

The female superiority in survival in clinical stage II cutaneous malignant melanoma

10 October 2023

70

1 reference

https://api.crossref.org/works/10.1002/JSO.2930250408

Endocrine influences on survival from malignant melanoma

10 October 2023

71

1 reference

https://api.crossref.org/works/10.1002/JSO.2930250408

Adverse effect of pregnancy on melanoma. A reappraisal

10 October 2023

72

1 reference

https://api.crossref.org/works/10.1002/JSO.2930250408

Glucocorticoid receptors, clinical characteristics, and implications for prognosis in chronic lymphocytic leukemia

10 October 2023

73

1 reference

https://api.crossref.org/works/10.1002/JSO.2930250408

Anterior resection versus abdominoperineal resection for cancer of the rectum and rectosigmoid. An analysis of 524 cases

10 October 2023

75

1 reference

https://api.crossref.org/works/10.1002/JSO.2930250408

Steroid receptor proteins in human meningiomas

10 October 2023

76

1 reference

https://api.crossref.org/works/10.1002/JSO.2930250408

Tamoxifen for lymphangioleiomyomatosis

10 October 2023

77

1 reference

https://api.crossref.org/works/10.1002/JSO.2930250408

Treatment of Intra-abdominal and Abdominal Wall Desmoid Tumors With Drugs That Affect the Metabolism of Cyclic 3', 5'-Adenosine Monophosphate

10 October 2023

78

1 reference

https://api.crossref.org/works/10.1002/JSO.2930250408

Indomethacin and ascorbate inhibit desmoid tumors

10 October 2023

79

1 reference

https://api.crossref.org/works/10.1002/JSO.2930250408

Steroid receptors in malignant skeletal tumors

10 October 2023

80

1 reference

https://api.crossref.org/works/10.1002/JSO.2930250408

The effect of pregnancy on intracranial meningiomas occurring about the optic chiasm.

10 October 2023

81

1 reference

https://api.crossref.org/works/10.1002/JSO.2930250408

10 October 2023

Identifiers

1 reference

18 September 2017

1 reference